1 – 10 of 150
- show: 10
- |
- sort: year (new to old)
- |
- Export
- 2021
- Corticosteroids and mRNA vaccines : a word of caution (2021) MOLECULAR THERAPY. 29(3). p.893-894
- Sterilizing immunity against SARS‐CoV‐2 infection in mice by a single‐shot and lipid amphiphile imidazoquinoline TLR7/8 agonist‐adjuvanted recombinant spike protein vaccine** (2021) ANGEWANDTE CHEMIE-INTERNATIONAL EDITION. 60(17). p.9467-9473
- Lipid-polyglutamate nanoparticle vaccine platform (2021) ACS APPLIED MATERIALS & INTERFACES. 13(5). p.6011-6022
- Corticosteroids and cellulose purification improve, respectively, the in vivo translation and vaccination efficacy of sa-mRNAs (2021) MOLECULAR THERAPY. 29(4). p.1370-1381
- OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer (2021) NPJ BREAST CANCER. 7(1).
- 2020
- Immune cells as tumor drug delivery vehicles (2020) JOURNAL OF CONTROLLED RELEASE. 327. p.70-87
- Sterilizing immunity against SARS-CoV-2 infection in mice by a single-shot and modified imidazoquinoline TLR7/8 agonist-adjuvanted recombinant spike protein vaccine (2020) bioRxiv.
- Imidazoquinoline-conjugated degradable coacervate conjugate for local cancer immunotherapy (2020) ACS BIOMATERIALS SCIENCE & ENGINEERING. 6(9). p.4993-5000
- The opposing effect of type I IFN on the T cell response by non-modified mRNA-lipoplex vaccines Is determined by the route of administration (2020) MOLECULAR THERAPY-NUCLEIC ACIDS. 22. p.373-381
- Potent and prolonged innate immune activation by enzyme-responsive imidazoquinoline TLR7/8 agonist prodrug vesicles (2020) JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. 142(28). p.12133-12139